• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬:一种涉及肿瘤进展和治疗耐药性的 N-甲基腺苷修饰的关键机制。

Autophagy: a critical mechanism of N-methyladenosine modification involved in tumor progression and therapy resistance.

机构信息

NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Oncotarget Gene, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/ Hunan Cancer Hospital, Changsha, China.

Xiangya School of Medicine, Central South University, Changsha, China.

出版信息

Cell Death Dis. 2024 Oct 28;15(10):783. doi: 10.1038/s41419-024-07148-w.

DOI:10.1038/s41419-024-07148-w
PMID:39468015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11519594/
Abstract

N-Methyladenosine (mA) is an evolutionarily highly conserved epigenetic modification that affects eukaryotic RNAs, especially mRNAs, and mA modification is commonly linked to tumor proliferation, progression, and therapeutic resistance by participating in RNA metabolism. Autophagy is an intracellular degradation and recycling biological process by which cells remove damaged organelles, protein aggregates, and other intracellular wastes, and release nutrients to maintain cell survival when energy is scarce. Recent studies have shown that mA modification plays a critical role in the regulation of autophagy, affecting the initiation of autophagy, the formation and assembly of autophagosomes, and lysosomal function by regulating critical regulatory molecules involved in the process of autophagy. Moreover, autophagy can also affect the expression of the three types of regulators related to mA, which in turn affects the levels of their target genes via mA modification. Thus, mA modification and autophagy form a sophisticated regulatory network through mutual regulation, which plays an important role in tumor progression and therapeutic resistance. In this manuscript, we reviewed the effects of mA modification on autophagy as well as the effects of autophagy on mA modification and the roles of the mA-autophagy axis in tumor progression and therapy resistance. Additionally, we summarized the value and application prospects of key molecules in the mA-autophagy axis in tumor diagnosis and therapy.

摘要

N6-甲基腺苷(m6A)是一种进化上高度保守的表观遗传修饰,影响真核 RNA,特别是 mRNAs,m6A 修饰通常通过参与 RNA 代谢与肿瘤增殖、进展和治疗抵抗有关。自噬是一种细胞内降解和回收的生物过程,通过该过程,细胞可以去除受损的细胞器、蛋白质聚集体和其他细胞内废物,并在能量匮乏时释放营养物质以维持细胞存活。最近的研究表明,m6A 修饰在自噬的调控中发挥着关键作用,通过调节自噬过程中涉及的关键调节分子,影响自噬的起始、自噬体的形成和组装以及溶酶体功能。此外,自噬还可以影响与 m6A 相关的三种调节因子的表达,进而通过 m6A 修饰影响其靶基因的水平。因此,m6A 修饰和自噬通过相互调节形成一个复杂的调控网络,在肿瘤进展和治疗抵抗中发挥着重要作用。在本文中,我们综述了 m6A 修饰对自噬的影响,以及自噬对 m6A 修饰的影响,以及 mA-自噬轴在肿瘤进展和治疗抵抗中的作用。此外,我们总结了 mA-自噬轴中关键分子在肿瘤诊断和治疗中的价值和应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/547e4f9ab694/41419_2024_7148_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/09e2bf815886/41419_2024_7148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/4af8e4ac603c/41419_2024_7148_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/0a6ec3718ed0/41419_2024_7148_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/8d1153499b64/41419_2024_7148_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/be04559180cb/41419_2024_7148_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/48334a1b3b1b/41419_2024_7148_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/547e4f9ab694/41419_2024_7148_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/09e2bf815886/41419_2024_7148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/4af8e4ac603c/41419_2024_7148_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/0a6ec3718ed0/41419_2024_7148_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/8d1153499b64/41419_2024_7148_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/be04559180cb/41419_2024_7148_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/48334a1b3b1b/41419_2024_7148_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f308/11519594/547e4f9ab694/41419_2024_7148_Fig7_HTML.jpg

相似文献

1
Autophagy: a critical mechanism of N-methyladenosine modification involved in tumor progression and therapy resistance.自噬:一种涉及肿瘤进展和治疗耐药性的 N-甲基腺苷修饰的关键机制。
Cell Death Dis. 2024 Oct 28;15(10):783. doi: 10.1038/s41419-024-07148-w.
2
Surmounting cancer drug resistance: New insights from the perspective of N-methyladenosine RNA modification.克服癌症药物耐药性:N6-甲基腺苷 RNA 修饰视角的新见解。
Drug Resist Updat. 2020 Dec;53:100720. doi: 10.1016/j.drup.2020.100720. Epub 2020 Aug 20.
3
Ferroptosis: a critical mechanism of N-methyladenosine modification involved in carcinogenesis and tumor progression.铁死亡:N6-甲基腺苷修饰参与肿瘤发生和进展的关键机制。
Sci China Life Sci. 2024 Jun;67(6):1119-1132. doi: 10.1007/s11427-023-2474-4. Epub 2024 Feb 28.
4
RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.RNA N6-甲基腺苷:自噬介导的抗癌药物耐药性中的新角色。
Br J Cancer. 2021 May;124(10):1621-1622. doi: 10.1038/s41416-021-01314-z. Epub 2021 Mar 15.
5
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.N6-甲基腺苷(m6A)修饰与环状 RNA 之间的相互调控在癌症中的作用:对治疗抵抗性的影响。
Mol Cancer. 2022 Jul 18;21(1):148. doi: 10.1186/s12943-022-01620-x.
6
RNA N -methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential.RNA N -甲基腺苷修饰在癌症干细胞与肿瘤免疫微环境的致命协作中的作用:现状与治疗潜力。
Clin Transl Med. 2021 Sep;11(9):e525. doi: 10.1002/ctm2.525.
7
Novel Insights into The Roles of N-methyladenosine (mA) Modification and Autophagy in Human Diseases.关于 N6-甲基腺苷(m6A)修饰和自噬在人类疾病中作用的新见解。
Int J Biol Sci. 2023 Jan 1;19(2):705-720. doi: 10.7150/ijbs.75466. eCollection 2023.
8
Interaction between N-methyladenosine (mA) modification and noncoding RNAs in cancer.N6-甲基腺苷(m6A)修饰与癌症中非编码 RNA 的相互作用。
Mol Cancer. 2020 May 22;19(1):94. doi: 10.1186/s12943-020-01207-4.
9
N-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target.N6-甲基腺苷在癌症免疫治疗中的作用:一个被低估的治疗靶点。
Front Immunol. 2021 Aug 30;12:697026. doi: 10.3389/fimmu.2021.697026. eCollection 2021.
10
Biological and pharmacological roles of mA modifications in cancer drug resistance.mA 修饰在癌症药物耐药性中的生物学和药理学作用。
Mol Cancer. 2022 Dec 14;21(1):220. doi: 10.1186/s12943-022-01680-z.

引用本文的文献

1
Mettl3-Mediated N6-Methyladenosine Modification Mitigates Ganglion Cell Loss and Retinal Dysfunction in Retinal Ischemia-Reperfusion Injury by Inhibiting FoxO1-Mediated Autophagy.Mettl3介导的N6-甲基腺苷修饰通过抑制FoxO1介导的自噬减轻视网膜缺血再灌注损伤中的神经节细胞损失和视网膜功能障碍。
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):58. doi: 10.1167/iovs.66.2.58.

本文引用的文献

1
METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.METTL16 通过自噬途径以 m6A 方式降解 PMEPA1 mRNA 抑制膀胱癌的增殖和顺铂化疗耐药性。
Int J Biol Sci. 2024 Feb 4;20(4):1471-1491. doi: 10.7150/ijbs.86719. eCollection 2024.
2
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer.WTAP/IGF2BP3轴对ULK1的调控增强了上皮性卵巢癌中的线粒体自噬和进展。
Cell Death Dis. 2024 Jan 29;15(1):97. doi: 10.1038/s41419-024-06477-0.
3
Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma.
自噬激活是 N6-甲基腺苷修饰调节肝细胞癌铁死亡所必需的。
Redox Biol. 2024 Feb;69:102971. doi: 10.1016/j.redox.2023.102971. Epub 2023 Dec 1.
4
mTORC1 Mediates Biphasic Mechano-Response to Orchestrate Adhesion-Dependent Cell Growth and Anoikis Resistance.mTORC1 介导双相机械反应以协调黏附依赖性细胞生长和抗失巢凋亡。
Adv Sci (Weinh). 2024 Feb;11(6):e2307206. doi: 10.1002/advs.202307206. Epub 2023 Dec 2.
5
YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.YY1受ALKBH5介导的m6A修饰调控,并通过靶向ATG4B促进自噬和癌症进展。
Aging (Albany NY). 2023 Sep 18;15(18):9590-9613. doi: 10.18632/aging.205037.
6
METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner.METTL14 通过 m6A-IGF2BP2 依赖性方式靶向自噬相关基因 RB1CC1 抑制口腔鳞状细胞癌的恶性进展。
Clin Sci (Lond). 2023 Sep 13;137(17):1373-1389. doi: 10.1042/CS20230219.
7
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.N6-甲基腺苷修饰调控 miR-146b 重塑肿瘤相关巨噬细胞,增强结直肠癌抗 PD-1 治疗。
Cell Oncol (Dordr). 2023 Dec;46(6):1731-1746. doi: 10.1007/s13402-023-00839-0. Epub 2023 Jul 5.
8
The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia.m6A 调节剂介导的阿糖胞苷敏感性和急性髓系白血病中的免疫细胞浸润特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11457-11469. doi: 10.1007/s00432-023-05029-x. Epub 2023 Jun 30.
9
METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.METTL16 促进糖酵解代谢重编程和结直肠癌进展。
J Exp Clin Cancer Res. 2023 Jun 20;42(1):151. doi: 10.1186/s13046-023-02732-y.
10
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential.人癌症中的癌胚蛋白IGF2BPs:功能、机制及治疗潜力
Biomark Res. 2023 Jun 6;11(1):62. doi: 10.1186/s40364-023-00499-0.